2% Royalty Shock at Alteogen Ripples Through Korean Biotech[K-Bio Pulse] 김새미 2026.01.22 오전 08:00 NGeneBio Hits Upper Price Limit After Adopting LG AI Research Institute’s Solution[K-Bio Pulse] 신민준 2026.01.21 오전 08:10 ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 김새미 2025.11.12 오후 06:05 Alteogen’s ‘Tergase Injection’ Clears Seoul Asan Medical Center’s Drug Committee 김승권 2025.03.05 오전 08:15 QuantaMatrix Hits Upper Limit on Growing Order Intake…Aptabio·Alteogen ↑[K-bio Pulse] 신민준 2025.07.17 오전 08:13 Ildong Joins Obesity Drug Race; Alteogen Floats KOSPI Relisting[K-Bio Pulse] 임정요 2025.07.08 오전 07:59 AI Diagnostics Poised to Elevate K-Bio’s Global Standing 류성 2025.07.15 오전 07:40 ABL Bio Shares Surge on GSK Licensing Deal [K-Bio Pulse] 김진수 2025.04.08 오전 07:58 Biotech Rallies as Four Firms Join Korea’s Top 10 Stock Gainers[K-Bio Pulse] 유진희 2025.05.28 오전 07:48 Excel Therapeutics, Alteogen Surge on Deal Hopes[K-bio Pulse] 김승권 2025.04.09 오전 08:12 더 보기 로딩중..